Investors
|
Careers
|
Contact Us
Company Overview
Company Overview
Management Team
Board of Directors
Scientific Advisory Board
Collaborations
Business Development
:
Product Pipeline
Product Pipeline
Partnered Programs
Elinogrel
Betrixaban
Proprietary Programs
PRT061103: Thromboxane Receptor Antagonist
Fxa Inhibitor Antidote
PRT062607: Syk-specific Inhibitor
Clinical Trials
Publications
:
Therapeutic Areas
Therapeutic Areas
Thrombosis Overview
Antiplatelet and Anticoagulant Markets
Rheumatoid Arthritis Overview
:
Newsroom
Newsroom
News Releases
Events Calendar
Portola in the News
Publications
Site Map
Site Map
Company Overview
Management Team
Board of Directors
Scientific Advisory Board
Collaborations
Business Development
Investors
Careers
Contact Us
Portola Profiles
Terms of Use
Privacy Policy
Product Pipeline
Partnered Programs
Elinogrel
Betrixaban
Proprietary Programs
PRT061103: Thromboxane
receptor antagonist
Fxa inhibitor antidote
PRT062607: Syk-specific
inhibitor
Clinical Trials
Publications
Therapeutic Areas
Thrombosis Overview
Antiplatelet and Anticoagulant Markets
Rheumatoid Arthritis Overview
Newsroom
News Releases
Events Calendar
Portola in the News
Publications